Ipca Labs profit leaps over 3-folds to Rs 445.68 crore in Q1
New Delhi: Drug firm Ipca Laboratories on Monday reported over three-fold jump in its consolidated net profit to Rs 445.68 crore for the quarter ended June due to robust sales.The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing.Consolidated total income stood at Rs 1,546.49 crore for the quarter...
New Delhi: Drug firm Ipca Laboratories on Monday reported over three-fold jump in its consolidated net profit to Rs 445.68 crore for the quarter ended June due to robust sales.
The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing.
Consolidated total income stood at Rs 1,546.49 crore for the quarter under consideration. It was Rs 1,098.53 crore in the same period year ago, it added.
Shares of Ipca Laboratories closed at Rs 2,099.60 per unit on BSE, up 7.36 per cent over the previous close.
Read also: Divi's Labs Profit Up 80.61 Percent To Rs 492.06 Crore In Q1
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd